|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$48,437,400 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$48,437,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-34.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-11-30 |
4 |
D |
$72.90 |
$714,639 |
D/D |
(9,803) |
416,928 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2014-02-12 |
4 |
AS |
$75.00 |
$1,265,625 |
D/D |
(16,875) |
111,099 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-06-30 |
4 |
A |
$75.84 |
$12,437 |
D/D |
164 |
369,180 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-11-17 |
4 |
AS |
$78.32 |
$783,173 |
D/D |
(10,000) |
416,731 |
0 |
% |
|
TECH |
Techne Corp |
Director |
|
2023-04-28 |
4 |
D |
$79.88 |
$349,635 |
D/D |
(4,377) |
34,983 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-11-09 |
4 |
D |
$81.77 |
$200,991 |
D/D |
(2,458) |
222,113 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2024-05-14 |
4 |
S |
$83.84 |
$335,377 |
D/D |
(4,000) |
36,608 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-31 |
4 |
A |
$84.53 |
$18,851 |
D/D |
223 |
235,310 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-06-30 |
4 |
A |
$85.91 |
$21,220 |
D/D |
247 |
338,095 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-02-15 |
4 |
D |
$85.97 |
$214,237 |
D/D |
(2,492) |
130,497 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-08 |
4 |
D |
$87.52 |
$147,296 |
D/D |
(1,683) |
235,087 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4/A |
S |
$88.06 |
$88,060 |
D/D |
(1,000) |
366,180 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4 |
S |
$89.35 |
$268,050 |
D/D |
(3,000) |
364,180 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-15 |
4 |
S |
$90.00 |
$180,000 |
D/D |
(2,000) |
367,180 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2015-06-09 |
4 |
S |
$92.53 |
$928,809 |
D/D |
(10,000) |
126,044 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-07-31 |
4 |
B |
$95.45 |
$176,583 |
D/D |
1,850 |
146,749 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-13 |
4 |
D |
$95.68 |
$479,261 |
D/D |
(5,009) |
196,730 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-15 |
4 |
D |
$97.23 |
$497,429 |
D/D |
(5,116) |
205,173 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-02-24 |
4 |
D |
$100.38 |
$480,118 |
D/D |
(4,783) |
122,745 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-03-07 |
4 |
S |
$102.44 |
$1,110,027 |
D/D |
(10,833) |
119,664 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-02-15 |
4 |
D |
$104.28 |
$448,821 |
D/D |
(4,304) |
118,360 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-12-20 |
4 |
D |
$105.87 |
$714,517 |
D/D |
(6,749) |
153,614 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
D |
$106.92 |
$157,493 |
D/D |
(1,473) |
143,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
S |
$107.06 |
$428,240 |
D/D |
(4,000) |
128,969 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-05-31 |
4 |
B |
$108.20 |
$108,202 |
D/D |
1,000 |
144,899 |
2.81 |
- |
|
165 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|